HMGB1 and neoplasm: These results suggest that tumor-derived HMGB1 promotes in vivo tumor growth through the inhibition of anti-tumor immunity by suppressing the infiltration of anti-tumor immune cells into the tumor microenvironment, and therefore, HMGB1 plays a negative role in the host defense against tumors.